EA200500452A1 - Способы лечения эректильной дисфункции у мужчин - Google Patents

Способы лечения эректильной дисфункции у мужчин

Info

Publication number
EA200500452A1
EA200500452A1 EA200500452A EA200500452A EA200500452A1 EA 200500452 A1 EA200500452 A1 EA 200500452A1 EA 200500452 A EA200500452 A EA 200500452A EA 200500452 A EA200500452 A EA 200500452A EA 200500452 A1 EA200500452 A1 EA 200500452A1
Authority
EA
Eurasian Patent Office
Prior art keywords
erectile dysfunction
treating erectile
men
methods
patient
Prior art date
Application number
EA200500452A
Other languages
English (en)
Russian (ru)
Inventor
Джеймс Л. Йиджер
Надир Бюйюктимкин
Сервет Бюйюктимкин
Original Assignee
Нексмед (Холдингс), Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,485 external-priority patent/US7105571B2/en
Application filed by Нексмед (Холдингс), Инк. filed Critical Нексмед (Холдингс), Инк.
Publication of EA200500452A1 publication Critical patent/EA200500452A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA200500452A 2002-09-06 2003-09-05 Способы лечения эректильной дисфункции у мужчин EA200500452A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/236,485 US7105571B2 (en) 2000-01-10 2002-09-06 Prostaglandin compositions and methods of treatment for male erectile dysfunction
US48327803P 2003-06-27 2003-06-27
PCT/US2003/027885 WO2004022064A1 (fr) 2002-09-06 2003-09-05 Procedes de traitement des troubles de l'erection chez l'homme

Publications (1)

Publication Number Publication Date
EA200500452A1 true EA200500452A1 (ru) 2005-10-27

Family

ID=31980977

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500452A EA200500452A1 (ru) 2002-09-06 2003-09-05 Способы лечения эректильной дисфункции у мужчин

Country Status (10)

Country Link
EP (1) EP1534297A1 (fr)
JP (1) JP2006512291A (fr)
KR (1) KR20050057245A (fr)
CN (1) CN1674912A (fr)
AU (1) AU2003273291A1 (fr)
CA (1) CA2493723A1 (fr)
EA (1) EA200500452A1 (fr)
IL (1) IL166273A0 (fr)
NO (1) NO20050658L (fr)
WO (1) WO2004022064A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
JP2006520788A (ja) * 2003-03-21 2006-09-14 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物による血管形成促進および方法
MXPA05010069A (es) * 2003-03-21 2005-11-23 Nexmed Holdings Inc Composiciones de prostaglandina para el tratamiento de la disfuncion erectil.
EP3266458A1 (fr) 2016-07-05 2018-01-10 Fagron B.V. Procédé et composition et kit pour traiter un dysfonctionnement érectile

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
WO2003070281A1 (fr) * 2002-02-15 2003-08-28 Nexmed (Holdings), Inc. Composition de prostaglandine pour le traitement des troubles de l'erection

Also Published As

Publication number Publication date
CN1674912A (zh) 2005-09-28
JP2006512291A (ja) 2006-04-13
EP1534297A1 (fr) 2005-06-01
NO20050658L (no) 2005-04-01
AU2003273291A1 (en) 2004-03-29
CA2493723A1 (fr) 2004-03-18
WO2004022064A1 (fr) 2004-03-18
IL166273A0 (en) 2006-01-15
KR20050057245A (ko) 2005-06-16

Similar Documents

Publication Publication Date Title
DE60335743D1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
EA200000563A1 (ru) Способы лечения женщин в постклимактерическом состоянии с применением ультранизких доз эстрогена
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
GB0318438D0 (en) Early entry
BE2012C040I2 (fr)
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
MX2007009032A (es) Formulacion para inyeccion de butanos catecolicos incluyendo compuestos ndga en animales.
EA200401345A1 (ru) Лечение гастропареза
ATE425253T1 (de) Tribonektine
ATE466595T1 (de) Verbindungen und methoden für das downregulating der effekte von tgf-beta
EA200500452A1 (ru) Способы лечения эректильной дисфункции у мужчин
PL377441A1 (pl) Sposób wytwarzania stereoizomeru glikopironiowego o konfiguracji R,R (lub S,S)
EA200300125A1 (ru) Применение каберголина для лечения полисистемной атрофии и прогрессирующего супрануклеарного паралича
ATE460938T1 (de) Morpholin-derivate zur verwendung als dopaminagonisten in der behandlung von u.a. sexueller dysfunktion
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.
EA200200798A1 (ru) Кальцилитические соединения
EA200500878A1 (ru) Кальцилитические соединения
PT910398E (pt) Metodo de estimulacao de cilios
EA200300388A1 (ru) 1-аминоалкилциклогексаны в качестве трипаноцидных агентов
ATE319839T1 (de) Verfahren zur verbesserung der transfektionseffizienz
ATE418929T1 (de) Austragvorrichtung für dentale zwecke